Editorial Board

Dr. Mohd Zulkiflee bin Abu Bakar

Dr. Mohd Zulkiflee bin Abu Bakar
Associate Professor
Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine,
University of Malaya
Malaysia

Biography :

KNOWLEDGE AND AWARENESS ABOUT PROSTATISM AMONG MALE PATIENTS WHO COME TO KLINIK KESIHATAN BUKIT KUDA, KLANG, 2009/2010, 60092  Marzuki, Pilot Study on the Prevalence of Otitis Media with Effusion in Children undergoing Cleft Palate Repair, 2011/2012, 90039  Shantini Jaganathan, Isolation of HDM from nasal vestibule and cavity  Mohd Hafiz Mahboob, "Audiological Outcome of Cochlear Implant in UMMC", 2011/2012  Numerous numbers of Masters Students

Research Interest :

A study on prevalence of posterior choanal stenosis in post irradiated NPC patient and to identify any predisposing factors, Principal Investigator (PI), 2009-2010, Geran Penyelidikan Universiti Malaya (UMRG), National  Chronic Rhinosinusitis and Nasal Polyposis Cohort Study, RM61,000, Co-Investigator, 2008-2012, Geran Penyelidikan Universiti Malaya (UMRG), National  Clinical applications of Medial Olivocochlear Bundle in Human (Neurophysiology), Co-Investigator, 2008-2012  Deep Neck Infection: Epidemiology and Clinical Status -A Local Spectrum, Student, 2004-2008, University of Malaya, University  Epithelial Migration of The Atelectatic Pars Flacida Tympanic Membrane, RM21,500, Principal Investigator (PI), 2012-2014, Short Term Research Fund (Vote F)(PJP), National  A Phase III, Open-label, Randomized, Multi-center Study of the Effects of Leukocyte Interleukin, Injection [Multikine*] Plus Standard of Care (Surgery + Radiotherapy or Surgery + Concurrent Chemo radiotherapy) in Subjects with Advanced Primary Squamous Cell Carcinoma of the Oral Cavity / Soft Palate Versus Standard of Care Only  A Phase III Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK3475-048)  A phase II, multi-centre, single arm, global study of MEDI4736 Monotherapy in patient with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - (HAWK)  A phase II, randomized, open-Label, multi-center, global study of MEDI4736 monotherapy, tremelimumab monotherapy, and MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - (CONDOR)  DEVELOPING A GENRE AND LINGUISTIC FRAMEWORK FOR THE TEACHING AND ASSESSMENT OF MEDICAL STUDENTS’ CASE PRESENTATIONS (UPM-UM)  Study on Epigenetic Changes in Nasopharyngeal Cancer (20159-1642)